All Type of News
Germany is largest pharmaceutical raw materials, radiological product exporter to Korea
The Korea Pharmaceutical Manufacturers Association says that Korea imported $547.7 million worth of pharmaceutical raw materials, finished products and diagnostic radiological products from Germany last year, 12.5 per...
Korea neglects R&D for new drugs
Korea is not investing enough in research and development (R&D) projects for new drugs, a report showed recently. This partly explains why Korea is lagging behind others in the pharmaceutical industry, the report said...
Government to introduce drug cost refund system
The National Health Insurance Corp. said on August 18 it plans to implement a drug cost refund system for one year starting this month on a trial basis, as part of efforts to get patients the life-saving drug as quick...
Shares of flu test kit and mask up
As H1N1 influenza has once again become a national public health concern in Korea, the share prices of Bioland, a local diagnostic kit maker, saw its equity prices surge 14.60% on 12,950 won on August 20.
Bioland s...
Drugmakers negative about advertisement of prescription drugs in media
The majority of pharmaceutical firms have expressed skepticism about the government plan to lift advertisement ban of prescription drugs in the media, according to the Ministry for Health, Welfare and Family Affairs.
...
Sales of prescription drugs top 779.4 billion won in July
The nation’s ethical sales in July swelled to 779.4 billion won last month, according to data released by securities firms.
The combined sales of the nine major domestic manufacturers, including Dong-A, Dongwha and...
3 original drug prices to fall by 20% in September
The insurance prices of three original drugs, such as Boryung’s Astrix, Otsuka’s Obcort and Janssen’s Reminyl will be reduced by 20% from the next month, the Ministry for Health, Welfare and Family Affairs said on Aug...
Top 10 import medicines in 2008 outlined
The nation imported Prevenar, a heptavalent vaccine, amounting to $44.26 million in 2008, according to data released by the Korea Pharmaceutical Manufacturers Association.
By import performance record, Glivec came ...
Careful approaches are needed over biosimilar business
The government will need to work out measures to push up with the controversial biosimilar business in more cautious manner, experts claimed.
They argued that generic drug companies are ready to make cheaper versio...
107 drugmakers produce cefaclor
A total of 107 pharmaceutical firms are engaged in manufacturing cefaclor, a third-generation antibiotic, according to data of the National Health Insurance Corporation which were released on August 17 frequently pres...
